3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
1
Optic Neuritis
1
Neuromyelitis Optica
1
Myelitis, Transverse
1
Myasthenia Gravis
1
Demyelinating Diseases
1
Interventions
fludarabine phosphate
6
Whole-Body Irradiation
5
Melphalan
5
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Cyclophosphamide
3
thymoglobulin
2
Tacrolimus
2
Methotrexate
2
Cyclosporine
2
Busulfan
2
Antilymphocyte Serum
2
Alemtuzumab
2
merphos
1
fludarabine
1
Thiotepa
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Muromonab-CD3
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Cyclosporins
1
Basiliximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hemoglobinuria, Paroxysmal
×
ravulizumab
×
Clear all
No trials found.